The COL2A1 gene SMED Strudwick type genetic test is a specialized diagnostic tool designed to detect mutations in the COL2A1 gene, which are associated with Spondyloepimetaphyseal Dysplasia (SMED) Strudwick type. This condition is a rare form of dwarfism characterized by skeletal abnormalities, including short stature, abnormal bone development, and other systemic issues. The test is crucial for early diagnosis and management of the condition, enabling healthcare providers to develop a tailored treatment plan for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab. The laboratory utilizes advanced genetic sequencing techniques to meticulously analyze the COL2A1 gene for any mutations that are indicative of SMED Strudwick type.
The cost of the COL2A1 gene SMED Strudwick type genetic test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the COL2A1 gene. For patients and families, the test offers invaluable insights into the genetic underpinnings of SMED Strudwick type, guiding decisions on surveillance, intervention, and family planning.
The DHCR7 Gene Smith-Lemli-Opitz Syndrome Genetic Test is a specialized diagnostic tool used to detect mutations in the DHCR7 gene, which are associated with Smith-Lemli-Opitz Syndrome (SLOS). SLOS is a congenital disorder characterized by physical malformations, developmental delay, and intellectual disabilities, resulting from a deficiency in the enzyme 7-dehydrocholesterol reductase. This enzyme plays a crucial role in the biosynthesis of cholesterol in the body.
The test involves analyzing the patient's DNA to identify any genetic mutations in the DHCR7 gene that may lead to the syndrome. It is a critical step in confirming a diagnosis of SLOS, allowing for early intervention, management of symptoms, and genetic counseling for affected families.
In the UAE, this genetic test is available at DNA Labs UAE, a leading provider of genetic testing services. The cost of the DHCR7 Gene Smith-Lemli-Opitz Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive testing service not only provides accurate diagnosis but also offers support and guidance for families navigating the implications of a genetic disorder.
The NSD1 Gene Sotos Syndrome Type 1 Genetic Test is a specialized diagnostic examination offered at DNA Labs UAE, designed to identify mutations in the NSD1 gene, which are primarily responsible for Sotos Syndrome Type 1. Sotos Syndrome is a genetic condition characterized by rapid growth during the early years of life, distinct facial features, and developmental delays. The NSD1 gene plays a crucial role in normal growth and brain development, and mutations in this gene can lead to the various symptoms associated with the syndrome.
The test is meticulously conducted to provide accurate and comprehensive results, which are essential for the diagnosis, management, and understanding of the condition's implications on the affected individual's health and development. With a cost of 4400 AED, the test is accessible to those who suspect they or their family members might be exhibiting symptoms of Sotos Syndrome Type 1 or to those seeking a definitive diagnosis following preliminary screenings or assessments.
DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring high-quality service and reliable results. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the NSD1 gene. The outcome of this test not only aids in confirming a diagnosis of Sotos Syndrome Type 1 but also provides crucial information for guiding treatment options and management strategies, ultimately enhancing the quality of life for those affected by the condition.
The "NFIX Gene Sotos-Like Syndrome Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the NFIX gene, which are associated with Sotos-like syndrome. This condition, characterized by overgrowth and developmental delays, shares similarities with Sotos syndrome but is caused by alterations in the NFIX gene rather than the NSD1 gene found in traditional Sotos syndrome. The test is crucial for accurate diagnosis, enabling targeted management and intervention strategies for affected individuals. Priced at 4400 AED, the test represents an essential investment in the health and well-being of individuals exhibiting symptoms suggestive of Sotos-like syndrome, providing families and healthcare professionals with vital genetic information to guide care and support.
The FOXP2 Gene Speech-Language Disorder Type 1 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the FOXP2 gene, which are known to be associated with speech and language disorders. This gene plays a crucial role in the development of the neural mechanisms involved in speech and language. Mutations in the FOXP2 gene can lead to difficulties in controlling the fine movements required for speech, leading to a condition often referred to as developmental verbal dyspraxia or speech-language disorder type 1.
The test is conducted through a comprehensive analysis of the patient's DNA to pinpoint any alterations in the FOXP2 gene that could be contributing to speech and language difficulties. This is crucial for early diagnosis and intervention, which can significantly improve the communication abilities of affected individuals through tailored speech and language therapy.
The cost of the FOXP2 Gene Speech-Language Disorder Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the expenses associated with the sophisticated genetic testing technologies and the expertise required to accurately interpret the results. By opting for this test, patients and their families can gain valuable insights into the genetic underpinnings of speech and language disorders, paving the way for personalized treatment plans and support.
The "MTRR Gene Spina Bifida Folate Sensitive Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the MTRR gene that may increase the risk of spina bifida in offspring. Spina bifida is a neural tube defect characterized by the incomplete development of the brain, spinal cord, or their protective coverings, and it's known that folate metabolism plays a crucial role in its prevention. The MTRR (methionine synthase reductase) gene is essential for the proper function of folate-dependent processes involved in DNA synthesis and repair.
This test is particularly valuable for individuals or couples planning a pregnancy who wish to assess their risk of having a child with spina bifida, especially if there's a family history of neural tube defects or related conditions. By examining the MTRR gene, the test can help in identifying genetic variations that might affect folate metabolism, providing crucial information for preventive measures, such as dietary folate supplementation.
The test is priced at 4400 AED and is conducted at the state-of-the-art facilities of DNA Labs UAE. The laboratory is equipped with advanced genetic testing technology to ensure accurate and reliable results. Following the test, genetic counseling is often recommended to help interpret the results and to discuss possible steps to mitigate the identified risks. This proactive approach empowers individuals with valuable insights into their genetic makeup, aiding in informed decision-making regarding family planning and preventive healthcare strategies.
The IFT172 gene plays a crucial role in the development of bones and other tissues within the body. Mutations in this gene are associated with Short-Rib Thoracic Dysplasia Type 10 with or without Polydactyly (SRTD10), a rare genetic disorder characterized by constricted thoracic cage, short ribs, shortened bones in the arms and legs, and in some cases, extra fingers or toes (polydactyly). This condition is part of a group of diseases known as ciliopathies, which are caused by dysfunction of cilia, microscopic hair-like structures that play a critical role in cellular signaling and organ development.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the IFT172 gene, providing crucial information for the diagnosis of Short-Rib Thoracic Dysplasia Type 10. This test is particularly valuable for families with a history of the condition or where prenatal diagnosis is considered. The cost of the test is 4400 AED and involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of genetic mutations associated with the disorder.
By confirming a diagnosis, this genetic test enables healthcare providers to offer appropriate clinical management and counseling for affected individuals and their families. It also aids in understanding the risk of recurrence in future pregnancies, allowing for informed decision-making. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing results, contributing to the effective diagnosis and understanding of Short-Rib Thoracic Dysplasia Type 10.
The WDR34 gene short-rib thoracic dysplasia type 11 with or without polydactyly genetic test is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to detect mutations in the WDR34 gene, which are known to cause short-rib thoracic dysplasia type 11, a rare genetic disorder. This condition is characterized by a narrow chest, short ribs, shortened bones in the arms and legs, and, in some cases, extra fingers or toes (polydactyly). The accurate identification of this genetic mutation can be crucial for early diagnosis, management, and understanding the inheritance pattern of the disorder within a family. The test is priced at 4400 AED and offers a comprehensive analysis for families seeking answers about this specific genetic condition.
The "IFT80 Gene Short-Rib Thoracic Dysplasia Type 2 with or Without Polydactyly Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the IFT80 gene. These mutations are known to cause Short-Rib Thoracic Dysplasia Type 2 (SRTD2), a rare genetic disorder characterized by short ribs, shortening of long bones, narrow chest, and sometimes, extra fingers or toes (polydactyly). This test is crucial for early diagnosis, allowing for appropriate management and genetic counseling for affected families. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the presence of the specific gene mutation.
The "DYNC2H1 Gene Short-Rib Thoracic Dysplasia Type 3 with or Without Polydactyly Genetic Test" is a specific diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the DYNC2H1 gene. This gene is crucial for the proper development of bones, particularly in the rib cage and limbs. Mutations in the DYNC2H1 gene can lead to Short-Rib Thoracic Dysplasia Type 3, a rare genetic disorder characterized by a narrow chest, short ribs, shortened bones in the arms and legs, and potentially polydactyly (the presence of extra fingers or toes). The condition is inherited in an autosomal recessive manner, meaning that a child needs to inherit two copies of the mutated gene (one from each parent) to be affected.
This genetic test is vital for early diagnosis, allowing for appropriate medical management and genetic counseling for affected families. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect mutations in the DYNC2H1 gene.
The cost of the test is 4400 AED (United Arab Emirates Dirham), reflecting the specialized nature of the test and the advanced technology used in the analysis. By opting for this test at DNA Labs UAE, individuals can expect a reliable diagnosis, which is crucial for managing the condition and understanding the risk for future pregnancies within the family.
